Use of dendritic cells to immunize against cancers overexpressing p53.
Lutzker
S G
SG
Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and The Cancer Institute of New Jersey, New Brunswick 08901, USA.
Lattime
E C
EC
D000256:Adenoviridae / Q000235:genetics; D000257:Adenoviridae Infections; D000818:Animals; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007114:Immunization; D008198:Lymph Nodes / Q000276:immunology / Q000473:pathology; D051379:Mice; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D014162:Transfection; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
D015704:CD4 Antigens; D016827:CD8 Antigens; D019496:Cancer Vaccines; D016159:Tumor Suppressor Protein p53